CA ATC C09AA05 · updated 2 Nov 2026
Ramipril shortage in Canada
Is there a Ramipril shortage in Canada?
Yes. As of 2 Nov 2026, 12 Ramipril products are reported short in Canada, the first since 15 Aug 2018. The company estimate for the return is 6 Nov 2026 (latest 20 Nov 2026). Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAR-RAMIPRIL (30 Caps) | MARCAN PHARMACEUTICALS INC | 15 Aug 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-RAMIPRIL (30 BLST) | MARCAN PHARMACEUTICALS INC | 10 Sep 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | JAMP-RAMIPRIL (30) | JAMP PHARMA CORPORATION | 7 Oct 2019 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RAMIPRIL (100) | JAMP PHARMA CORPORATION | 1 Oct 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RAMIPRIL (500's Bottle) | SUN PHARMA CANADA INC | 3 Dec 2025 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RAMIPRIL (500) | SANIS HEALTH INC | 8 Dec 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RAMIPRIL (500) | SANIS HEALTH INC | 8 Dec 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RAMIPRIL (500) | SANIS HEALTH INC | 1 Jan 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RAMIPRIL (100 BTL) | APOTEX INC | 16 Jun 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RAMIPRIL (30 BLS) | APOTEX INC | 28 Jul 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RAMIPRIL (30 BLS) | APOTEX INC | 8 Sep 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RAMIPRIL (500 BTL) | APOTEX INC | 6 Oct 2026 | 6 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.